Monoclonal antibodies (mAbs) have become one of the most important classes of biopharmaceutical
products, and they continue to dominate the universe of biopharmaceutical markets …

As the Coronavirus Disease 2019 (COVID-19), which is caused by the novel SARS-CoV-2,
continues to spread rapidly around the world, there is a need for well validated serological …

Membrane proteins are attractive targets for monoclonal antibody (mAb) discovery and
development. Although several approved mAbs against membrane proteins have been isolated …

The rapidly spreading Coronavirus Disease (COVID-19) pandemic, caused by the severe
acute respiratory syndrome coronavirus (SARS-CoV-2), represents an unprecedented serious …

Naringenin (NAR), a flavonoid mainly found in citrus and grapefruits, has proven anti-cancer
activities. However, the poor water solubility and low bioavailability of NAR limits its use as …

A critical factor in the successful isolation of new antibodies by phage display is the presentation
of a correctly folded antigen. While this is relatively simple for soluble proteins which …

Pseudomonas aeruginosa is an opportunistic gram-negative human pathogen that causes
a wide range of infections, including nosocomial infections. Aside from the intrinsic and …

Thymoquinone (TQ), a natural polyphenol, has been associated with various pharmacological
responses; however, low bioavailability of TQ limits its clinical application. Thus, a novel …

The Coronavirus Disease 2019 (COVID-19), caused by SARS-CoV-2, continues to spread
globally with significantly high morbidity and mortality rates. Antigen-specific responses are of …

Nanoparticles (NPs) in contact with a biological medium are rapidly comprehended by a
number of protein molecules resulting in the formation of an NP–protein complex called protein …